Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology: Finding Bullish Indications At The End Of 2019 (NASDAQ:PBYI) | Seeking Alpha
Puma Wins 5-Year Extension of Patent on Main Breast Cancer Treatment Drug Nerlynx - Los Angeles Business Journal
We Think Puma Biotechnology (NASDAQ:PBYI) Can Stay On Top Of Its Debt | Nasdaq
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology, Inc.
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
PUMA BIOTECHNOLOGY: FDA Grants Orphan Drug Designation to Puma Biotechnology's NERLYNX® for the Treatment of Breast Cancer Patients with Brain Metastases | FDA Health News
Puma Biotechnology | Evaluate
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology Surging
Puma Biotechnology, Inc.Analytics - Traffic, Statistics and Competitor tracking | WatchMyCompetitor
Why Clovis Oncology, Immunomedics, and Puma Biotechnology All Spiked Today | The Motley Fool
Puma Biotechnology, Inc. 2020 Current Report 8-K
Puma Biotechnology
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive
Puma Biotechnology, Knight Therapeutics sign license deal to commercialize NERLYNX in Canada - Pharmaceutical Business review
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
PumaBiotech (@pumabiotech) / Twitter
After making $1M+ on illegal trades, former Puma Biotechnology executive gets prison term | Fierce Pharma
A Top Puma Bio Exec Resigns Ahead of FDA Panel, Analysts Defend With Conflicting Stories - TheStreet
Puma Biotechnology
Puma Biotech's Neratinib Fails To Extend Overall Survival In Brain Cancer Trial
Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
Pint-Pharma - Puma Biotechnology and Pint Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Latin America
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Exhibitor Puma Biotechnology 11-6 - Scripps CME Connection
